Patients who obtain compounded GLP-1s online sometimes come into visits thinking their medications are approved by the Food and Drug Administration, said Ramachandran, a physician and health services researcher at the Yale School of Medicine
Dont inject it into a vein or muscle
The combined SUSTAIN, FLOW, and PIONEER trial programs have enrolled more than 15,000 patients and consistently demonstrated benefits beyond glycemic control, including reduced cardiovascular events, slower progression of kidney disease, and modest weight loss
Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimers and Parkinsons diseases correlate with disease status and features of pathology
Novo Nordisk has already launched an oral GLP-1 for weight management in the US, marking a step towards more accessible treatment options